These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 5440356)
1. Depression of tuberculin delayed hypersensitivity by live attenuated mumps virus. Kupers TA; Petrich JM; Holloway AW; St Geme JW J Pediatr; 1970 May; 76(5):716-21. PubMed ID: 5440356 [No Abstract] [Full Text] [Related]
2. Persistence of immunity four years following Jeryl Lynn strain live mumps virus vaccine. Weibel RE; Buynak EB; Stokes J; Hilleman MR Pediatrics; 1970 May; 45(5):821-6. PubMed ID: 5444402 [No Abstract] [Full Text] [Related]
3. [Anti-mumps vaccination with a live attenuated vaccine in a children's collective]. Drouhet V; Celers J; Minvielle A Bull Acad Natl Med; 1970 Jun; 154(23):570-6. PubMed ID: 4922864 [No Abstract] [Full Text] [Related]
4. [Anti-mumps vaccination with live attenuated vaccine in a children's community]. Drouhet V; Celers J; Minvielle A; Lévy-Thierry S Ann Pediatr (Paris); 1971 Apr; 18(4):277-85. PubMed ID: 5574000 [No Abstract] [Full Text] [Related]
5. Use of attenuated live mumps virus vaccine during a "virgin soil" epidemic of mumps on St. Paul Island, Alaska. Maynard JE; Shramek G; Noble GR; Deinhardt F; Clark P Am J Epidemiol; 1970 Nov; 92(5):301-6. PubMed ID: 5473777 [No Abstract] [Full Text] [Related]
6. Studies on live attenuated mumps vaccine. II. Follow-up study on the efficacy of Biken Vaccine. Isomura S; Ozaki T; Morishima T; Nagayoshi S; An S Biken J; 1976 Sep; 19(3):115-8. PubMed ID: 1016214 [TBL] [Abstract][Full Text] [Related]
8. Studies on live mumps virus vaccine. IV. Clinical and serological follow-up 2 year and 3 years after vaccination. Yamanishi K; Takahashi M; Kurimura T; Ueda S; Suzuki N Biken J; 1971 Sep; 14(3):259-65. PubMed ID: 5156905 [No Abstract] [Full Text] [Related]
9. Depression of established delayed hepersensitivity by mumps virus. Hall CB; Kantor FS J Immunol; 1972 Jan; 108(1):81-5. PubMed ID: 4110805 [No Abstract] [Full Text] [Related]
12. Protection of mumps in children with various underlying diseases: application of a live attenuated mumps and trivalent measles-rubella-mumps (MRM) vaccines in these children. Kanesaki T; Baba K; Tsuda N; Yabuuchi H; Yamanishi K; Takahashi M Biken J; 1986 Dec; 29(3-4):63-71. PubMed ID: 3304276 [TBL] [Abstract][Full Text] [Related]
14. The timing of tuberculin tests in relation to immunization with live viral vaccines. Brickman HF; Beaudry PH; Marks MI Pediatrics; 1975 Mar; 55(3):392-6. PubMed ID: 1143978 [TBL] [Abstract][Full Text] [Related]
18. [Experience with increasing the immunogenic properties of live vaccine against epidemic parotitis]. Nasibov MN; Smorodintsev AA Vopr Virusol; 1968; 13(3):336-40. PubMed ID: 5749862 [No Abstract] [Full Text] [Related]
19. [Prevention of mumps]. Kaptsova TI Feldsher Akush; 1983; 48(4):7-10. PubMed ID: 6552997 [No Abstract] [Full Text] [Related]
20. Public acceptance of mumps immunization. Report of one year's experience offering live mumps vaccine in a public health clinic and school immunization program. Jones PH JAMA; 1969 Aug; 209(6):901-5. PubMed ID: 5819464 [No Abstract] [Full Text] [Related] [Next] [New Search]